Literature DB >> 9213072

The vascular dementia of Fabry's disease.

M F Mendez1, T M Stanley, N M Medel, Z Li, D T Tedesco.   

Abstract

Fabry's disease, a rare X-linked disorder of glycosphingolipid metabolism, can present as an insidious dementia in middle or later life. This genetic disorder produces a deficiency of alpha-galactosidase A which results in the deposition of glycosphingolipids in blood vessel walls in the brain as well as in the kidney, heart, peripheral nerves, and other organs. Among the cerebrovascular manifestations of this disorder is a vascular dementia from involvement of multiple small penetrating blood vessels. Fabry's disease is a consideration in the workup of an otherwise unexplained vascular dementia, particularly in males less than 65 years of age.

Entities:  

Mesh:

Year:  1997        PMID: 9213072     DOI: 10.1159/000106640

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  10 in total

Review 1.  Young onset dementia.

Authors:  E L Sampson; J D Warren; M N Rossor
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

Review 2.  Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.

Authors:  Marianne Rohrbach; Joe T R Clarke
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Cognitive and psychological functioning in Fabry disease.

Authors:  Linda Sigmundsdottir; Michel C Tchan; Alex A Knopman; Graham C Menzies; Jennifer Batchelor; David O Sillence
Journal:  Arch Clin Neuropsychol       Date:  2014-11       Impact factor: 2.813

4.  Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.

Authors:  Po Phyu; Aine Merwick; Indran Davagnanam; Fay Bolsover; Fatima Jichi; Claudia Wheeler-Kingshott; Xavier Golay; Deralynn Hughes; Lisa Cipolotti; Elaine Murphy; Robin H Lachmann; David John Werring
Journal:  Neurology       Date:  2018-03-21       Impact factor: 9.910

5.  Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study.

Authors:  Perri Segal; Yoav Kohn; Yehuda Pollak; Gheona Altarescu; Esti Galili-Weisstub; Annick Raas-Rothschild
Journal:  J Inherit Metab Dis       Date:  2010-06-15       Impact factor: 4.982

Review 6.  Fabry disease in the era of enzyme replacement therapy: a renal perspective.

Authors:  Monique E Cho; Jeffrey B Kopp
Journal:  Pediatr Nephrol       Date:  2004-04-03       Impact factor: 3.714

7.  Postmortem diagnosis of Fabry disease with acromegaly and a unique vasculopathy.

Authors:  Masaki Takao; Taisuke Mori; Hideki Orikasa; Haengphil Oh; Kinuko Suzuki; Atsuo Koto; Kazuto Yamazaki
Journal:  Virchows Arch       Date:  2007-07-12       Impact factor: 4.064

Review 8.  Cognitive dysfunction and depression in Fabry disease: a systematic review.

Authors:  Fay E Bolsover; Elaine Murphy; Lisa Cipolotti; David J Werring; Robin H Lachmann
Journal:  J Inherit Metab Dis       Date:  2013-08-16       Impact factor: 4.982

Review 9.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

10.  Clinical Case Presentation - Fabry's Disease.

Authors: 
Journal:  EJIFCC       Date:  2004-06-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.